MOZ-TIF2 inhibits transcription by nuclear receptors and p53 by impairment of CBP function

Molecular and Cellular Biology

Volumn 25, Issue 3, 2005, Pages 988-1002

  Kindle, Karin B ^a   Troke, Philip J F ^a,e   Collins, Hilary M ^a   Matsuda, Sachiko ^a   Bossi, Daniela ^b   Bellodi, Cristian ^a   Kalkhoven, Eric ^c   Salomoni, Paolo ^a   Pelicci, Pier Giuseppe ^b   Minucci, Saverio ^b   Heery, David M ^a,d  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; CELL NUCLEUS RECEPTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; NUCLEAR RECEPTOR COACTIVATOR 2; PROTEIN MOZ; PROTEIN P300; PROTEIN P53; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL PROLIFERATION; CHROMOSOME REARRANGEMENT; CONTROLLED STUDY; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE FUSION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION;

ACETYLTRANSFERASES; ANIMALS; BONE MARROW CELLS; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COS CELLS; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE ACETYLTRANSFERASES; HL-60 CELLS; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; NUCLEAR PROTEINS; NUCLEAR RECEPTOR COACTIVATOR 2; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA; MURINAE;

EID: 19944433555     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.25.3.988-1002.2005     Document Type: Article

References (66)

1. Aguiar, R. C., A. Chase, S. Coulthard, D. H. Macdonald, M. Carapeti, A. Reiter, J. Sohal, A. Lennard, J. M. Goldman, and N. C. Cross. 1997. Abnormalities of chromosome band 8p11 in leukemia: two clinical syndromes can be distinguished on the basis of MOZ involvement. Blood 90:3130-3135.
2. Akhtar, A., and P. B. Becker. 2001. The histone H4 acetyltransferase MOF uses a C2HC zinc finger for substrate recognition. EMBO Rep. 2:113-118.
3. Alcalay, M., N. Meani, V. Gelmetti, A. Fantozzi, M. Fagioli, A. Orleth, D. Riganelli, C. Sebastiani, E. Cappelli, C. Casciari, M. T. Sciurpi, A. R. Mariano, S. P. Minardi, L. Luzi, H. Muller, P. P. Di Fiore, G. Frosina, and P. G. Pelicci. 2003. Acute myeloid leukemia fusion proteins deregulate genes involved in stem cell maintenance and DNA repair. J. Clin. Investig. 112:1751-1761.
4. Anzick, S. L., J. Kononen, R. L. Walker, D. O. Azorsa, M. M. Tanner, X. Y. Guan, G. Sauter, O. P. Kallioniemi, J. M. Trent, and P. S. Meltzer. 1997. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277:965-968.
5. Baumann, C. T., H. Ma, R. Wolford, J. C. Reyes, P. Maruvada, C. Lim, P. M. Yen, M. R. Stallcup, and G. L. Hager. 2001. The glucocorticoid receptor interacting protein 1 (GRIP1) localizes in discrete nuclear foci that associate with ND10 bodies and are enriched in components of the 26S proteasome. Mol. Endocrinol. 15:485-500.
6. Billio, A., E. J. Steer, G. Pianezze, M. Svaldi, M. Casin, B. Amato, P. Coser, and N. C. Cross. 2002. A further case of acute myeloid leukaemia with inv(8)(p11q13) and MOZ-TIF2 fusion. Haematologica 87:ECR15.
7. Blobel, G. A. 2000. CREB-binding protein and p300: molecular integrators of hematopoietic transcription. Blood 95:745-755.
8. Borrow, J., V. P. Stanton, Jr., J. M. Andresen, R. Becher, F. G. Behm, R. S. Chaganti, C. I. Civin, C. Disteche, I. Dube, A. M. Frischauf, D. Horsman, F. Mitelman, S. Volinia, A. E. Watmore, and D. E. Housman. 1996. The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein. Nat. Genet. 14:33-41.
9. Carapeti, M., R. C. Aguiar, J. M. Goldman, and N. C. Cross. 1998. A novel fusion between MOZ and the nuclear receptor coactivator TIF2 in acute myeloid leukemia. Blood 91:3127-3133.
10. Chaffanet, M., L. Gressin, C. Preudhomme, V. Soenen-Cornu, D. Birnbaum, and M. J. Pebusque. 2000. MOZ is fused to p300 in an acute monocytic leukemia with t(8;22). Genes Chromosomes Cancer 28:138-144.
11. Champagne, N., N. R. Bertos, N. Pelletier, A. H. Wang, M. Vezmar, Y. Yang, H. H. Heng, and X. J. Yang. 1999. Identification of a human histone acetyltransferase related to monocytic leukemia zinc finger protein. J. Biol. Chem. 274:28528-28536.
12. Champagne, N., N. Pelletier, and X. J. Yang. 2001. The monocytic leukemia zinc finger protein MOZ is a histone acetyltransferase. Oncogene 20:404-409.
13. Chen, H., R. J. Lin, R. L. Schiltz, D. Chakravarti, A. Nash, L. Nagy, M. L. Privalsky, Y. Nakatani, and R. M. Evans. 1997. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 90:569-580.
14. Collins, S. J., K. A. Robertson, and L. Mueller. 1990. Retinoic acid-induced granulocytic differentiation of HI-60 myeloid-leukemia cells is mediated directly through the retinoic acid receptor (RAR-alpha). Mol. Cell. Biol. 10:2154-2163.
15. Coulthard, S., A. Chase, K. Orchard, A. Watmore, A. Vora, J. A. M. Goldman, and D. M. Swirsky. 1998. Two cases of inv(8)(p11q13) in AML with erythrophagocytosis: a new cytogenetic variant. Br. J. Haematol. 124:561-563.
16. Deguchi, K., P. M. Ayton, M. Carapeti, J. L. Kutok, C. S. Snyder, I. R. Williams, N. C. Cross, C. K. Glass, M. L. Cleary, and D. G. Gilliland. 2003. MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBP. Cancer Cell 3:259-271.
17. Demarest, S. J., M. Martínez-Yamout, J. Chung, H. Chen, W. Xu, H. J. Dyson, R. M. Evans, and P. E. Wright. 2002. Mutual synergistic folding in recruitment of CBP/p300 by p160 nuclear receptor coactivators. Nature 415:549-553.
18. Doucas, V., M. Tini, D. A. Egan, and R. M. Evans. 1999. Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling. Proc. Natl. Acad. Sci. USA 96:2627-2632.
19. Du, C., R. L. Redner, M. P. Cooke, and C. Lavau. 1999. Overexpression of wild-type retinoic acid receptor alpha (RARalpha) recapitulates retinoic acid-sensitive transformation of primary myeloid progenitors by acute promyelocytic leukemia RARalpha-fusion genes. Blood 94:793-802.
20. Gaughan, L., M. E. Brady, S. Cook, D. E. Neal, and C. N. Robson. 2001. Tip60 is a co-activator specific for class I nuclear hormone receptors. J. Biol. Chem. 276:46841-46848.
21. Giordano, A., and M. L. Avantaggiati. 1999. p300 and CBP: partners for life and death. J. Cell. Physiol. 181:218-230.
22. Goodman, R. H., and S. Smolik. 2000. CBP/p300 in cell growth, transformation, and development. Genes Dev. 14:1553-1577.
23. Heery, D. M., E. Kalkhoven, S. Hoare, and M. G. Parker. 1997. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 387:733-736.
24. Hong, H., K. Kohli, A. Trivedi, D. L. Johnson, and M. R. Stallcup. 1996. GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors. Proc. Natl. Acad. Sci. USA 93:948-4952.
25. Insinga, A., S. Monestiroli, S. Ronzoni, R. Carbone, M. Pearson, G. Pruneri, G. Viale, E. Appella, P. Pelicci, and S. Minucci. 2004. Impairment of p53 acetylation, stability and function by an oncogenic transcription factor. EMBO J. 23:1144-1154.
26. Jacobson, S., and L. Pillus. 1999. Modifying chromatin and concepts of cancer. Curr. Opin. Genet. Dev. 9:175-184.
27. James, S. Y., M. A. Williams, A. C. Newland, and K. W. Colston. 1999. Leukemia cell differentiation: cellular and molecular interactions of retinoids and vitamin D. Gen. Pharmacol. 32:43-154.
28. Kalkhoven, E., J. E. Valentine, D. M. Heery, and M. G. Parker. 1998. Isoforms of steroid receptor co-activator 1 differ in their ability to potentiate transcription by the oestrogen receptor. EMBO J. 17:232-243.
29. Kang-Decker, N., C. Tong, F. Boussouar, D. J. Baker, W. Xu, A. A. Leontovich, W. R. Taylor, P. K. Brindle, and J. M. van Deursen. 2004. Loss of CBP causes T cell lymphomagenesis in synergy with p27Kip1 insufficiency. Cancer Cell. 5:177-189.
30. Kasper, L. H., P. K. Brindle, C. A. Schnabel, C. E. Pritchard, M. L. Cleary, and J. M. van Deursen. 1999. CREB binding protein interacts with nucleoporin-specific FG repeats that activate transcription and mediate NUP98-HOXA9 oncogenicity. Mol. Cell. Biol. 19:764-776.
31. Kim, M. Y., S. J. Hsiao, and W. L. Kraus. 2001. A role for coactivators and histone acetylation in estrogen receptor alpha-mediated transcription initiation. EMBO J. 20:6084-6094.
32. Kitabayashi, I., Y. Aikawa, L. A. Nguyen, A. Yokoyama, and M. Ohki. 2001. Activation of AML1-mediated transcription by MOZ and inhibition by the MOZ-CBP fusion protein. EMBO J. 20:7184-7196.
33. Kung, A. L., V. I. Rebel, R. T. Bronson, L. E. Ch'ng, C. A. Sieff, D. M. Livingston, and T. P. Yao. 2000. Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP. Genes Dev. 14:272-277.
34. Kuwata, T., I. M. Wang, T. Tamura, R. M. Ponnamperuma, R. Levine, K. L. Holmes, H. C. Morse, L. M. De Luca, and K. Ozato. 2000. Vitamin A deficiency in mice causes a systemic expansion of myeloid cells. Blood 95:3349-3356.
35. Lavau, C., J. M. Heard, O. Danos, and A. Dejean. 1996. Retroviral vectors for the transduction of the PML-RARalpha fusion product of acute promyelocytic leukemia. Exp. Hematol. 24:544-551.
36. Liang, J., L. Prouty, B. J. Williams, M. A. Dayton, and K. L. Blanchard. 1998. Acute mixed lineage leukemia with an inv(8)(p11q13) resulting in fusion of the genes for MOZ and TIF2. Blood 92:2118-2122.
37. Lill, N. L., S. R. Grossman, D. Ginsberg, J. DeCaprio, and D. M. Livingston. 1997. Binding and modulation of p53 by p300/CBP coactivators. Nature 387:823-827.
38. Livengood, J. A., K. E. S. Scaggin, K. Van Orden, S. J. McBryant, R. Edayathumangalam, P. J. Laybourn, and J. K. Nyborg. 2002. p53 Transcriptional activity is mediated through the SRC1-interacting domain of CBP/p300. J. Biol. Chem. 277:9054-9061.
39. Matsuda, S., J. C. Harries, M. Viskaduraki, P. J. F. Troke, K. B. Kindle, C. M. Ryan, and D. M. Heery. 2004. A conserved alpha-helical motif mediates the binding of diverse nuclear proteins to the SRC1 interaction domain of CBP. J. Biol. Chem. 279:14055-14064.
40. McCampbell, A., J. P. Taylor, A. A. Taye, J. Robitschek, M. Li, J. Walcott, D. Merry, Y. H. Chai, H. Paulson, G. Sobue, and K. H. Fischbeck. 2000. CREB-binding protein sequestration by expanded polyglutamine. Hum. Mol. Genet. 9:2197-2202.
41. Minucci, S., S. Monestiroli, S. Giavara, S. Ronzoni, F. Marchesi, A. Insinga, D. Diverio, P. Gasparini, M. Capillo, E. Colombo, C. Matteucci, F. Contegno, F. Lo-Coco, E. Scanziani, A. Gobbi, and P. G. Pelicci. 2002. PML-RAR induces promyelocytic leukemias with high efficiency following retroviral gene transfer into purified murine hematopoietic progenitors. Blood 100:2989-2995.
42. Murati, A., J. Adelaide, C. Popovici, M. J. Mozziconacci, C. Arnoulet, M. Lafage-Pochitaloff, D. Sainty, D. Birnbaum, and M. Chaffanet. 2003. A further case of acute myelomonocytic leukemia with inv(8) chromosomal rearrangement and MOZ-NCOA2 gene fusion. Int. J. Mol. Med. 12:423-428.
43. Nucifora, F. C., M. Sasaki, M. F. Peters, H. Huang, J. K. Cooper, M. Yamada, H. Takahashi, S. Tsuji, J. Troncoso, V. L. Dawson, T. M. Dawson, and C. A. Ross. 2001. Interference by huntingtin and atrophin-1 with CBP-mediated transcription leading to cellular toxicity. Science 291:2423-2428.
44. Oike, Y., N. Takakura, A. Hata, T. Kaname, M. Akizuki, Y. Yamaguchi, H. Yasue, K. Araki, K. Yamamura, and T. Suda. 1999. Mice homozygous for a truncated form of CREB-binding protein exhibit defects in hematopoiesis and vasculo-angiogenesis. Blood 93:2771-2779.
45. Olsson, I., U. Gullberg, I. Ivhed, and K. Nilsson. 1983. Induction of differentiation of the human histiocytic lymphoma cell-line U-937 by 1-alpha,25-dihydroxycholecalciferol. Cancer Res. 43:5862-5867.
46. Onate, S. A., S. Y. Tsai, M. J. Tsai and B. W. O'Malley. 1995. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270:1354-1357.
47. Panagopoulos, I., M. R. Teixeira, F. Micci, J. Hammerstrom, M. Isaksson, B. Johansson, F. Mitelman, and S. Heim. 2000. Acute myeloid leukemia with inv(8)(p11q13). Leuk. Lymphoma 39:651-656.
48. Panagopoulos, I., T. Fioretos, M. Isaksson, U. Samuelsson, R. Billstrom, B. Strombeck, F. Mitelman, and B. Johansson. 2001. Fusion of the MORF and CBP genes in acute myeloid leukemia with the t(10;16)(q22;p13). Hum. Mol. Genet. 10:395-404.
49. Parrado, A., C. Chomienne, and R. A. Padua. 2000. Retinoic acid receptor alpha (RAR alpha) mutations in human leukemia. Leuk. Lymphoma 39:271-282.
50. Pizzimenti, S., S. Laurora, F. Briatore, C. Ferretti, M. U. Dianzani, and G. Barrera. 2002. Synergistic effect of 4-hydroxynonenal and PPAR ligands in controlling human leukemic cell growth and differentiation. Free Radic. Biol. Med. 32:33-245.
51. Rebel, V. I., A. L. Kung, E. A. Tanner, H. Yang, R. T. Bronson, and D. M. Livingston. 2002. Distinct roles for CREB-binding protein and p300 in hematopoietic stem cell self-renewal. Proc. Natl. Acad. Sci. USA 99:14789-14794.
52. Scoggin, K. E. S., A. Ulloa, and J. K. Nyborg. 2001. The oncoprotein tax binds the SRC1-interacting domain of CBP/p300 to mediate transcriptional activation. Mol. Cell. Biol. 21:5520-5530.
53. Scolnick, D. M., N. H. Chehab, E. S. Stavridi, M. C. Lien, L. Caruso, E. Moran, S. L. Berger, and T. D. Halazonetis. 1997. CREB-binding protein and p300/CBP-associated factor are transcriptional coactivators of the p53 tumor suppressor protein. Cancer Res. 57:3693-3696.
54. Sheppard, H. M., J. C. Harries, S. Hussain, C. Bevan, and D. M. Heery. 2001. Analysis of the steroid receptor coactivator 1 (SRC1)-CREB binding protein interaction interface and its importance for the function of SRC1. Mol. Cell. Biol. 21:39-50.
55. Siegel, R. M., F. K. Chan, D. A. Zacharias, R. Swofford, K. L. Holmes, R. Y. Tsien, and M. J. Lenardo. 2000. Measurement of molecular interactions in living cells by fluorescence resonance energy transfer between variants of the green fluorescent protein. Sci. STKE 38:PL1.
56. Sterner, D. E., and S. L. Berger. 2000. Acetylation of histones and transcription-related factors. Microbiol. Mol. Biol. Rev. 64:435-459.
57. Sundstrom, C., and K. Nilsson. 1976. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int. J. Cancer 17:565-577.
58. Surapureddi, S., S. Yu, H. Bu, T. Hashimoto, A. V. Yeldandi, P. Kashireddy, M. Cherkaoui-Malki, C. Qi, Y. J. Zhu, M. S. Rao, and J. K. Reddy. 2002. Identification of a transcriptionally active peroxisome proliferator-activated receptor alpha-interacting cofactor complex in rat liver and characterization of PRIC285 as a coactivator. Proc. Natl. Acad. Sci. USA 99:11836-11841.
59. Tenen, D. G., R. Hromas, J. D. Licht, and D. E. Zhang. 1997. Transcription factors, normal myeloid development, and leukemia. Blood 90:489-519.
60. Torchia, J., D. W. Rose, J. Inostroza, Y. Kamei, S. Westin, C. K. Glass, and M. G. Rosenfeld. 1997. The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature 387:677-684.
61. Trecca, D., L. Longo, A. Biondi, L. Cro, R. Calori, F. Grignani, A. T. Maiolo, P. G. Pelicci, and A. Neri. 1994. Analysis of p53 gene mutations in acute myeloid leukemia. Am. J. Hematol. 46:304-309.
62. Voegel, J. J., M. J. Heine, M. Tini, V. Vivat, P. Chambon, and H. Gronemeyer. 1998. The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways. EMBO J. 17:507-519.
63. Wiederschain, D., H. Kawai, J. Gu, A. Shilatifard, and Z. M. Yuan. 2003. Molecular basis of p53 functional inactivation by the leukemic protein MLL-ELL. Mol. Cell. Biol. 23:4230-4246.
64. Yang, X. J. 2004. The diverse superfamily of lysine acetyltransferases and their roles in leukemia and other diseases. Nucleic Acids Res. 32:959-976.
65. Yao, T. P., S. P. Oh, M. Fuchs, N. D. Zhou, L. E. Ch'ng, D. Newsome, R. T. Bronson, E. Li, D. M. Livingston, and R. Eckner. 1998. Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell 93:361-372.
66. Zhong, S., P. Salomoni, P. P. Pandolfi. 2000. The transcriptional role of PML and the nuclear body. Nat. Cell. Biol. 2:E85-E90.